Fenwick Represents Tamarind Bio in $13.6M Funding
Fenwick represented Tamarind Bio, maker of state-of-the-art molecular AI models usable out of the box, in its $13.6 million funding, including a $12 million Series A funding. The Series A round was led by Dimension Capital with participation from Y Combinator.
Tamarind Bio will use the funds to build the infrastructure for AI-powered drug discovery. More information can be obtained from the company announcement.
The Fenwick transaction team was led by corporate partner Lara Foster.